Gemcitabine Selectively Eliminates Splenic Gr-1 + /CD11b + Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity

作者: Eiji Suzuki , Veena Kapoor , Arminder Singh Jassar , Larry R. Kaiser , Steven M. Albelda

DOI: 10.1158/1078-0432.CCR-05-0883

关键词: Interleukin 21Cancer immunotherapyMyeloidCancer researchImmune systemBiologyMyeloid-derived Suppressor CellImmunotherapyTumor suppressor geneImmunologyInterleukin 12

摘要: … + ) cells in the spleens of animals bearing large tumors derived from five cancer lines grown in … of myeloid suppressor cells found in the spleens of animals bearing large tumors with no …

参考文章(30)
Anna K Nowak, Bruce W S Robinson, Richard A Lake, Gemcitabine Exerts a Selective Effect on the Humoral Immune Response Implications for Combination Chemo-immunotherapy Cancer Research. ,vol. 62, pp. 2353- 2358 ,(2002)
J. P. Matthews, M. Prechel, M. A. Wright, M. R. I. Young, I. Malik, Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide. Journal of Immunology. ,vol. 156, pp. 1916- 1922 ,(1996)
Blondineth Peláez, José A. Campillo, José A. López-Asenjo, José L. Subiza, Cyclophosphamide Induces the Development of Early Myeloid Cells Suppressing Tumor Cell Growth by a Nitric Oxide-Dependent Mechanism The Journal of Immunology. ,vol. 166, pp. 6608- 6615 ,(2001) , 10.4049/JIMMUNOL.166.11.6608
Sergei Kusmartsev, Yulia Nefedova, Daniel Yoder, Dmitry I. Gabrilovich, Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. Journal of Immunology. ,vol. 172, pp. 989- 999 ,(2004) , 10.4049/JIMMUNOL.172.2.989
Bond Almand, Joseph I. Clark, Ekaterina Nikitina, James van Beynen, Nicholas R. English, Stella C. Knight, David P. Carbone, Dmitry I. Gabrilovich, Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. Journal of Immunology. ,vol. 166, pp. 678- 689 ,(2001) , 10.4049/JIMMUNOL.166.1.678
Vincenzo Bronte, Elisa Apolloni, Anna Cabrelle, Roberto Ronca, Paolo Serafini, Paola Zamboni, Nicholas P. Restifo, Paola Zanovello, Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. Blood. ,vol. 96, pp. 3838- 3846 ,(2000) , 10.1182/BLOOD.V96.12.3838
Dmitry Gabrilovich, Yulia Nefedova, Sergei Kusmartsev, Fengdong Cheng, Eduardo Sotomayor, Bin Yu, Richard Lush, All-trans-Retinoic Acid Eliminates Immature Myeloid Cells from Tumor-bearing Mice and Improves the Effect of Vaccination Cancer Research. ,vol. 63, pp. 4441- 4449 ,(2003)
Richard S. Hotchkiss, Kevin W. Tinsley, Jia-Ji Hui, Katherine C. Chang, Paul E. Swanson, Anne M. Drewry, Timothy G. Buchman, Irene E. Karl, p53-Dependent and -Independent Pathways of Apoptotic Cell Death in Sepsis The Journal of Immunology. ,vol. 164, pp. 3675- 3680 ,(2000) , 10.4049/JIMMUNOL.164.7.3675
Hyam I. Levitsky, J. Thomas August, Tzyy Choou Wu, Kevin F. Staveley-O'Carroll, Frank G. Guarnieri, Ken Yu Lin, Drew M. Pardoll, Treatment of Established Tumors with a Novel Vaccine That Enhances Major Histocompatibility Class II Presentation of Tumor Antigen Cancer Research. ,vol. 56, pp. 21- 26 ,(1996)
M. Rita I. Young, Mark A. Wright, Yvonne Lozano, M. Margaret Prechel, Janet Benefield, John P. Leonetti, Sharon L. Collins, Guy J. Petruzzelli, Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte‐macrophage colony‐stimulating factor and contained CD34+ natural suppressor cells International Journal of Cancer. ,vol. 74, pp. 69- 74 ,(1997) , 10.1002/(SICI)1097-0215(19970220)74:1<69::AID-IJC12>3.0.CO;2-D